2/13/2014 9:56:03 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report fourth quarter and full-year 2013 financial results before the NASDAQ Global Market opens on Thursday, February 27, 2014. Subsequently, at 8:00 a.m., Eastern Time, Chris Garabedian, Sarepta’s president and chief executive officer, and Sandy Mahatme, Sarepta’s chief financial officer, will host a conference call to discuss fourth quarter and full-year financial results and to provide a corporate update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by